Intercept Pharmaceuticals (ICPT) PT Raised to $146 at Wells Fargo
Tweet
Share
E-mailGet Alerts ICPT Hot Sheet
Price: $19.00 --0%
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 19
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 19
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough raised the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $146.00 (from $120.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Bunzl Plc. (BNZL:LN) (BZLFY) PT Raised to GBP28 at JPMorgan
- BNP Paribas Exane Upgrades L'Oreal SA (OR:FP) (LRLCY) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
